Home
Quality Matters

Main navigation

  • Supply Chain
  • Global Health
  • Dietary Supplements & Food

Mobile Menu

  • Global Health
  • Medicines
  • Dietary Supplements & Food
  • Contributors
  • Videos
  • USP.org
  • Contact us

Follow Us

  • LinkedIn
  • Twitter
  • Facebook
  • Youtube
Profile picture for user fa@usp.org

Fouad Atouf, Ph.D.

Vice President, Global Biologics
Twitter

Fouad Atouf leads all scientific activities related to the development and maintenance of documentary and reference standards for biologics and antibiotics, and oversees the biologics laboratories in USP–U.S. and USP–India. His department supports the work of the associated USP Expert Committees. Dr. Atouf has been at USP for over 10 years and served in a variety of scientific leadership roles including being the regional champion for the Middle East and North Africa Region, where he helped facilitate programs designed to enhance the understanding of the role of regulations and standards in the registration of medicinal products. Dr. Atouf has strong background and experience in the development and regulation of cellular and tissue-based products. Prior to joining USP in 2006, his research at the U.S. National Institutes of Health focused on developing methods for the in vitro generation of cell-based therapies for diabetes. Dr. Atouf is the author of numerous publications in peer-reviewed journals and a frequent speaker at national and international scientific conferences. Dr. Atouf earned his Master’s degree in Biochemistry and his Ph.D. in Cell Biology from the Pierre & Marie Curie University, Paris, France.

Medicines
 // July 24, 2018

Rapid Microbial Methods: The Need for Speed in Cell and Gene Therapies

When patients are administered biological treatments created from their own bodies - autologous r

Profile picture for user fa@usp.org
Fouad Atouf, Ph.D.
Cell and DNA strand
Medicines
 // May 03, 2018

Solutions to help ensure biopharmaceutical quality

By the year 2020, biopharmaceuticals are estimated to account for 50% of the most successful phar

Profile picture for user fa@usp.org
Fouad Atouf, Ph.D.
Chromosomes
Medicines
 // March 01, 2018

Standards are evolving to help industry produce complex, quality assured biologic medicines

Highly complex biologics such as proteins, monoclonal antibodies, and cell and gene therapies inc

Profile picture for user fa@usp.org
Fouad Atouf, Ph.D.
Drops falling from a pipette

Pagination

  • Newer posts ‹ Newer posts
  • Page 1
  • Page 2
  • Current page 3

Get the latest from Quality Matters to your inbox

Follow Us

  • LinkedIn
  • Twitter
  • Facebook
  • Youtube

Footer

  • Contributors
  • Videos
  • USP.org
  • Contact

Footer Copyright

  • Commenting Policy
  • Privacy Policy
  • Terms of Use

© The United States Pharmacopeial Convention